Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.732
Peer-review started: January 4, 2021
First decision: May 3, 2021
Revised: May 16, 2021
Accepted: June 25, 2021
Article in press: June 25, 2021
Published online: July 15, 2021
Processing time: 186 Days and 20.9 Hours
Laparoscopic liver resection (LLR) for colorectal liver metastases (CRLM) has become the gold standard in specialized centers and for well-selected patients and procedures.
Little is known concerning patient-related and peri-operative factors that could play a role in survival outcomes associated with LLR for CRLM.
The main objective was to provide an extensive summary of reported outcomes and prognostic factors associated with LLR for CRLM.
A systematic review was performed in PubMed, EMBASE, Web of Science and the Cochrane Library, after which thorough screening was performed and data was extracted for qualitative analysis.
Qualitative analysis of 77 full-text publications shows that LLR for CRLM is safe, feasible and provides oncological efficiency. This is true for more complex laparoscopic procedures as well. Results on prognostic factors affecting long-term outcomes for LLR for CRLM are scarce.
Besides short-term benefits, satisfactory oncological efficiency is reported for LLR for CRLM.
Little is still known about prognostic factors affecting long-term outcomes of LLR for CRLM, and future prospective multicenter randomized controlled trials are needed to provide robust evidence.
